FP
EVH icon

Foundry Partners’s Evolent Health EVH Stock Holding History

Foundry Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-215,325
Closed -$2.42M – 270
2024
Q4 		$2.42M Sell
215,325
-139,773
-39% -$2.46M 0.12% 201
2024
Q3 		$10M Buy
+355,098
New +$9.15M 0.5% 58

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Foundry Partners's EVH Position: Q1 2025 in Review

Foundry Partners sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 215,325 shares — an estimated $2.42M sold.

Foundry Partners first reported a position in EVH in Q3 2024 and held it in 2 quarters. The position peaked at $10M in Q3 2024. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • Foundry Partners reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • Foundry Partners sold 215,325 Evolent Health shares in Q1 2025, an estimated $2.42M.
  • Foundry Partners first reported a position in Evolent Health in Q3 2024 and held it in 2 quarters.
  • Foundry Partners's Evolent Health position peaked at $10M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.